ECSP024363A - REPLACED 1-AMINOALQUIL-LACTAMAS AND ITS USE AS ANTAGONIST OF MUSCARINIC RECEPTORS - Google Patents
REPLACED 1-AMINOALQUIL-LACTAMAS AND ITS USE AS ANTAGONIST OF MUSCARINIC RECEPTORSInfo
- Publication number
- ECSP024363A ECSP024363A EC2002004363A ECSP024363A ECSP024363A EC SP024363 A ECSP024363 A EC SP024363A EC 2002004363 A EC2002004363 A EC 2002004363A EC SP024363 A ECSP024363 A EC SP024363A EC SP024363 A ECSP024363 A EC SP024363A
- Authority
- EC
- Ecuador
- Prior art keywords
- muscarinic receptors
- aminoalquil
- lactamas
- antagonist
- replaced
- Prior art date
Links
- 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 title abstract 2
- 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000029578 Muscle disease Diseases 0.000 abstract 1
- 208000021642 Muscular disease Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 210000002460 smooth muscle Anatomy 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Esta invención se refiere a compuestos que son generalmente antagonistas de los receptores muscarínicos M2/M3 y que están generalmente por la fórmula en donde X;Y y Z son -O-, -8- 0>N-R4 y los demás sustituyentes tienen los significados definidos en la especificación; o "profarmacos", isomeros individuales, mezclas racemicas o no racemicas de isomeros, y sales farmacéuticamente aceptables o solvatos de los mismos. La invención se refiere además a composiciones farmacéuticas que contienen tales compuestos, a un proceso para su obtención y a su utilización para el tratamiento de enfermedades asociadas con trastornos del músculo liso.This invention relates to compounds that are generally antagonists of M2 / M3 muscarinic receptors and that are generally by the formula wherein X; Y and Z are -O-, -8- 0> N-R4 and the other substituents have the meanings defined in the specification; or "prodrugs", individual isomers, racemic or non-racemic mixtures of isomers, and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds, a process for obtaining them and their use for the treatment of diseases associated with smooth muscle disorders.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20748300P | 2000-05-25 | 2000-05-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP024363A true ECSP024363A (en) | 2003-03-31 |
Family
ID=32849292
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2002004363A ECSP024363A (en) | 2000-05-25 | 2002-11-25 | REPLACED 1-AMINOALQUIL-LACTAMAS AND ITS USE AS ANTAGONIST OF MUSCARINIC RECEPTORS |
| EC2002004362A ECSP024362A (en) | 2000-05-25 | 2002-11-25 | REPLACED 1-AMINOALQUIL-LACTAMAS AND ITS USE AS ANTAGONIST OF MUSCARINIC RECEPTORS |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2002004362A ECSP024362A (en) | 2000-05-25 | 2002-11-25 | REPLACED 1-AMINOALQUIL-LACTAMAS AND ITS USE AS ANTAGONIST OF MUSCARINIC RECEPTORS |
Country Status (2)
| Country | Link |
|---|---|
| EC (2) | ECSP024363A (en) |
| ZA (2) | ZA200208895B (en) |
-
2002
- 2002-11-01 ZA ZA200208895A patent/ZA200208895B/en unknown
- 2002-11-06 ZA ZA200209029A patent/ZA200209029B/en unknown
- 2002-11-25 EC EC2002004363A patent/ECSP024363A/en unknown
- 2002-11-25 EC EC2002004362A patent/ECSP024362A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200208895B (en) | 2004-02-19 |
| ZA200209029B (en) | 2004-02-06 |
| ECSP024362A (en) | 2003-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR033377A1 (en) | DERIVATIVES OF BENZOCICLOALQUILENILAMINA AS ANTAGONISTS OF MUSCARINIC RECEPTORS | |
| UY26729A1 (en) | HETEROCYCLIC ALKYLAMINES AS ANTAGONISTS OF MUSCARINIC RECEPTORS | |
| ES2158814B1 (en) | PIRROLIDINE DERIVATIVES ANTAGONIST RECEIVER CCR-3 | |
| PA8580301A1 (en) | NEW BENZOIMIDAZOL DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS | |
| UY28026A1 (en) | 4-PIPERAZINILBENCENOSULFONILINDOLES AND USES OF THE SAME. | |
| CR9834A (en) | [1,8] NAFTIRIDIN-2-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF EZQUIZOPHRENIA | |
| UY28135A1 (en) | PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH | |
| UY27322A1 (en) | NEW INDOL DERIVATIVES WITH AFFINITY FOR THE 5-HT6 RECEIVER | |
| PA8547901A1 (en) | 4-PIPERACINYLINDOL DERIVATIVES WITH 5-HT6 RECEPTOR AFFINITY | |
| PA8575401A1 (en) | DERIVATIVES OF BENZOCONDENSED HETEROARILAMIDE OF USEFUL TIENOPIRIDINS AS THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE SAME AND METHODS FOR USE | |
| UY28105A1 (en) | INDAZOL DERIVATIVES AS CRF ANTAGONISTS | |
| UY30398A1 (en) | "USE OF CGRP ANTAGONISTS (A), THEIR ENANTINMEROS, DIASTERNMEROS, MIXTURES AND PHARMACUTICALLY ACCEPTABLE SALTS TO PREPARE MEDICINES, AND COMPOSITIONS THAT CONTAIN THEM" | |
| UY27023A1 (en) | FENYL KETON DERIVATIVES REPLACED AS IP ANTAGONISTS | |
| ECSP088967A (en) | MUSCARINIC RECEIVER AGONISTS THAT ARE EFFECTIVE IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA | |
| UY26919A1 (en) | DERIVATIVES OF QUINAZOLINE AS ALFA ADRENERGIC ANTAGONISTS - 1 | |
| UY27685A1 (en) | INDOLIL-UREA DERIVED FROM USEFUL TIENOPIRIDINS AS ANTIANGIOGEN AGENTS, AND PROCEDURES FOR USE | |
| CO5611124A2 (en) | BENZOFURAN DERIVATIVES SUBSTITUTED USEFUL IN THE TREATMENT OF HYPER-PROLIFERATIVE DISORDERS | |
| PT1919475E (en) | Tetrahydro- beta-carbolin-sulfonamide derivatives as 5-ht6 ligands | |
| UY29412A1 (en) | N-SULFONYLAMINOFENILETIL-2-PHENOXYACETAMIDE SUBSTITUTED COMPOUNDS. | |
| ECSP056192A (en) | 3-FLUORO-PIPERIDINS AS ANTAGONISTS OF NMDA / NR2B | |
| MXPA04005313A (en) | Aminotetralin derivatives as muscarinic receptor antagonists. | |
| PA8540601A1 (en) | DERIVATIVES OF ALCOXICARBONILAMINOTETRAZOLIL PHENYLL OR BENZOIC ALCOXICARBONYLAMINE ACID AS IP ANTAGONISTS | |
| ECSP024363A (en) | REPLACED 1-AMINOALQUIL-LACTAMAS AND ITS USE AS ANTAGONIST OF MUSCARINIC RECEPTORS | |
| MXPA05011476A (en) | Imidazolin-2-ylaminophenyl amides as ip antagonists. | |
| UY29733A1 (en) | ACETYLENE PIPERAZINS AS ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS |